What Health-Care Affordability Crisis?
The National Review | Sally C. Pipes
April 25, 2021
Despite the pandemic, between February 2020 and February 2021, U.S. household income rose 13 percent, according to the Commerce Department. Again, that extra income did not go to health care. In fact, consumer spending on health care remained down year-on-year as recently as January.
|
|
Dr. Henry Miller – A COVID-19 Update and Progress on Vaccinations
PRI's Next Round Podcast | Dr. Henry Miller
April 27, 2021
This week’s guest is Dr. Henry Miller, PRI senior fellow in health care studies. In addition to being a physician, Dr. Miller was a former official at the FDA and founding director of the FDA’s Office of Biotechnology. Dr. Miller provides an update on the pandemic, the progress of vaccine distribution, and his perspective on the CDC’s pause on the use of the Johnson & Johnson vaccine. Co-hosts Rowena and Tim discuss Biden’s first 100 days, the recall effort, and new gubernatorial candidate Caitlyn Jenner.
Listen here. . .
|
|
Here They Go Again: The Democratic Obsession with Drug Price Controls Will Harm Patients and Diminish Innovation
PRI's Right By the Bay Blog | Wayne Winegarden
April 26, 2021
An analysis by the Congressional Budget Office (CBO) came to a similar conclusion. The CBO estimated that reference pricing could reduce drug industry revenues by up to $1 trillion over 10 years. Drug companies devote about 20 percent of their revenues to R&D, which indicates that any reference pricing scheme would shortchange R&D by hundreds of billions of dollars over the next decade.
Read more. . .
|
|
Europe Negotiates A Poor Vaccine Rollout
Forbes.com | Sally C. Pipes
April 26, 2021
Months before regulators approved the vaccines, most developed countries struck deals with manufacturers to order hundreds of millions of doses. The EU did secure lower prices. It’s paying $15 to $19 per dose for the Pfizer-BioNTech vaccine—less than the $20 a dose the United States agreed to pay.
Read more. . .
|
|
|
|
